v3.25.2
Revenue Recognition (Tables)
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table represents Evolent’s revenue disaggregated by line of business and product type (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2025202420252024
Medicaid$193,018 $217,068 $381,142 $432,192 
Medicare109,042 268,673 224,360 555,633 
Commercial and other142,268 161,404 322,475 298,973 
Total$444,328 $647,145 $927,977 $1,286,798 
Performance Suite$267,917 $461,602 $570,938 $909,820 
Specialty Technology and Services Suite81,401 81,515 164,222 170,518 
Administrative Services55,880 60,770 113,071 119,339 
Cases39,130 43,258 79,746 87,121 
Total$444,328 $647,145 $927,977 $1,286,798 
Schedule of Contract with Customer, Asset and Liability
The following table provides information about receivables, contract assets and deferred revenue from contracts with customers as of June 30, 2025 and December 31, 2024 (in thousands):
June 30, 2025December 31, 2024
Short-term receivables (1)
$357,401 $413,346 
Short-term deferred revenue2,333 2,507 
Long-term deferred revenue330 — 
————————
(1)Excludes pharmacy rebate receivable and pharmacy claims receivable.

Changes in deferred revenue for the six months ended June 30, 2025 are as follows (in thousands):
Deferred revenue
Balance as of beginning-of-period$2,507 
Reclassification to revenue, as a result of performance obligations satisfied(1,465)
Cash received in advance of satisfaction of performance obligations1,621 
Balance as of end of period$2,663